Avonex (interferon beta-1a) for multiple sclerosis
The FDA will soon approve Avonex (interferon beta-1a) for multiple sclerosis. It's also being considered by HPB.
Avonex is a beta-interferon...similar to Betaseron.
Beta-interferons help reduce the frequency of relapses in patients with the relapsing-remitting form of MS. They may also slow the progression of the disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive